Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
significant fold » significant force (Expand Search), significant co (Expand Search), significant all (Expand Search)
fold decrease » fold increase (Expand Search), fold increased (Expand Search), fold increases (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
significant fold » significant force (Expand Search), significant co (Expand Search), significant all (Expand Search)
fold decrease » fold increase (Expand Search), fold increased (Expand Search), fold increases (Expand Search)
-
3601
Line graph showing the values of inflammatory cytokines at baseline and after treatment.
Published 2025Subjects: -
3602
Baseline descriptive characteristics of trial participants (n = 140) with and without dizziness.
Published 2024Subjects: -
3603
-
3604
-
3605
-
3606
-
3607
Frequency distribution of SOLEC at baseline and follow-ups in the NSEIT and NSE groups.
Published 2024Subjects: -
3608
-
3609
Baseline and Post-Treatment Results of Echocardiographic Variables in Each Experimental Group.
Published 2025Subjects: -
3610
-
3611
-
3612
-
3613
Baseline descriptive characteristics of trial participants with dizziness, by treatment group.
Published 2024Subjects: -
3614
-
3615
Baseline and Post-Treatment Serum Cytokine Levels in Each Investigational Group.
Published 2025Subjects: -
3616
Relative abundance of microbiota in colonic content at the genus level (n = 5).
Published 2025Subjects: -
3617
-
3618
Baseline and Post-Treatment Serum Levels of NT-proBNP in Each Investigational Group.
Published 2025Subjects: -
3619
Variables obtained from the SF-36 quality of life questionnaire in each experimental group.
Published 2025Subjects: -
3620